Kevin Mc Cool
About Kevin Mc Cool
Kevin Mc Cool is a Project Manager currently employed at Adaptimmune since 2021. He has extensive experience in project management and laboratory roles, having previously worked at WuXi AppTec and Ancillare, LP.
Current Role at Adaptimmune
Kevin Mc Cool serves as a Project Manager at Adaptimmune, a role he has held since 2021. His responsibilities involve overseeing various projects within the organization, contributing to the advancement of cell therapy solutions. Adaptimmune is known for its innovative approaches in the field of immunotherapy, specifically focusing on T-cell therapies for cancer treatment. Mc Cool's experience in project management supports the company's mission to develop effective therapies.
Previous Experience at WuXi AppTec
Prior to his current position, Kevin Mc Cool had an extensive tenure at WuXi AppTec, where he held multiple roles. He worked as a Senior Laboratory Technician from 2014 to 2015 and as an Associate Laboratory Technician from 2013 to 2014. He later transitioned to project management, serving as Project Manager Biologics Testing from 2018 to 2021 and as Cell Therapy Project Manager from 2015 to 2017. His diverse roles at WuXi AppTec provided him with a solid foundation in laboratory operations and project management.
Experience at Ancillare, LP
Kevin Mc Cool worked as a Project Manager at Ancillare, LP for a period of nine months in 2017 to 2018. In this role, he was responsible for managing projects related to the biopharmaceutical supply chain. His experience at Ancillare contributed to his skills in project oversight and coordination, further enhancing his capabilities in the life sciences sector.
Educational Background in Biology
Kevin Mc Cool earned a Bachelor of Science degree in Biology/Biological Sciences from Coastal Carolina University, completing his studies from 2009 to 2012. This educational background provided him with a comprehensive understanding of biological principles, which he applies in his professional roles within the life sciences industry.